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Background: Intra-vascular Ultrasound (IVUS) use during Percutaneous Coronary Intervention (PCI) of native coronaries has been used to study 
lesion and vessel characteristics. It is unknown whether routine IVUS use in PCI of a saphenous vein graft (SVG) is beneficial.
Methods: A cohort of 543 patients who underwent SVG PCI ( 375 in IVUS group, 171 in the no IVUS group) were followed clinically up to 1 year 
and the clinical events were recorded and compared between the two groups. Patients presenting with myocardial infarction, cardiogenic shock, and 
multi-vessel or native vessel PCI were excluded. The primary composite endpoints were in-hospital major complications and major adverse cardiac 
events (MACE) at 1 year. Peri-procedural MI was defined as maximum troponin I greater then 3 times the baseline troponin I.
Results: Baseline and procedural characteristics were similar [see Table]. IVUS group had significantly longer procedural length and higher 
restenosis lesions. In-hospital complications, peri-procedural myocardial infarction, and no-reflow phenomenon were similar between the two groups. 
At 1 year, IVUS group had significantly higher MACE then the no IVUS group (22.7% vs 14.6%, p=0.03). On multivariate analysis, IVUS was not an 
independent predictor of MACE. [HR, 1.57 (0.95-2.60), p=0.07)
Conclusion: Routine IVUS for SVG PCI is safe but does not improve in-hospital or long term outcomes.
Table 
Baseline Characteristics 
(n=546)
IVUS
(n=375)
No IVUS
(n=171)
p value
Male 287/ 373 (76.9%) 131/170 (77.1%) 0.976
African American 33/ 375 (8.8%) 15/171 (8.8%) 0.991
Hypertension 311/ 374 (83.2%) 141/ 170 (82.9%) 0.951
Hyperlipidemia 333/ 375 (88.8%) 150/167 (89.8%) 0.725
Diabetes Mellitus Type 2 146/ 372 (39.2%) 72/ 170 (42.4%) 0.494
Unstable Angina Presentation 273/ 371 (73.6%) 128/ 171 (74.9%) 0.754
Procedural Characteristics
Number of Diseased Vessels 2.63 +/- 0.64 2.60 +/- 0.60 0.477
Procedure Length, (minutes) 78.55 +/- 64.83 54.98 +/- 26.69 <0.001 
Drug Eluting Stent 83/121 (68.6%) 99/ 115 (86.1%) 0.001
Bivalirudin 76/375 (20.3%) 78/ 171 (45.6%) <0.001
Heparin 272/375 (72.5%) 80/ 171 (46.8%) <0.001
Glycoprotein IIb/IIIa inhibitor 97/ 360 (26.9%) 40/ 169 (23.7%) 0.423
Restenosis Lesion 156/518 (30.1%) 28/242 (11.6%) <0.001
Distal protection device 76/ 263 (28.9%) 54/ 182 (29.7%) 0.860
Direct Stenting 78/ 241 (32.4%) 67/ 163 (41.1%) 0.072
In-Hospital outcomes
In-Hospital Complications
(Death, QWMI, CABG)
1/375 (0.3%) 3/171 (1.8%) 0.093 
Major Bleeding
(GI, Hct drop, Major Hematoma)
10/ 375 (2.7%) 1/ 171 (0.6%) 0.186
Subacute Stent Thrombosis 0/375 (0.0%) 0/ 171 (0.0%) -
No reflow 7/ 489 (1.4% 1/ 240 (0.4%) 0.283
Peri-Procedural MI * 108/375 (28.8%) 44/ 171 (25.73%) 0.458
Outcomes at 1 year
MACE, ( Death, QWMI, TVR) 85/ 375 (22.7%) 25/ 171 (14.6%%) 0.030 
Death 21/ 371 (5.7%) 14/ 171 (8.2%) 0.266
MI 18/364 (4.9%) 2/166 (1.2%) 0.036 
TVR 66/367 (18.0%) 13/ 167 (7.8%) 0.002 
Stent Thrombosis 0/ 375 (0.0%) 1/ 171 (0.6%) 0.313
